SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Introduction to HIV Persistence on ART- Denise Hsu, BSc, MBBS, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Turning Challenges into Opportunities: Preventing and Treating HIV Infection among Adolescents- Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVSView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Novel Treatment Strategies for LMICs- Pedro Cahn, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Transitioning to Sustainable Mechanisms for Priority Public Health Programmes in The Western Pacific- Naoko Ishikawa, MD, MSc, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Transitioning from International to Domestic Funding: Experiences in the Asia Pacific- Ravipa Vannakit, RN, MScView Slideset
EMEamonn MurphySlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019The UNAIDS perspective- Eamonn MurphyView Slideset
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Virtual elimination of Hepatitis C virus (HCV) from an inner city general practiceView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Changes in Liver Fibrosis in Patients with HCV / HIV Coinfection After Treatment with Sofosbuvir / DaclatasvirView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Prevalence and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: Results of a national surveyView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Different performances of various rapid enzyme immunoassays (EIA) for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) to detect asymptomatic CT/NG infectionsView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Comparable efficiency of point-of-care and machine-based NAAT in detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) using pooled vs. individual specimens from oropharynx, rectum and urethra.View Abstract
